Impact of comorbidities on the deterioration of skeletal muscle dysfunction among COPD patients

Poberezhets, V.; Skoczyński, S.; Demchuk, A.; Oraczewska, A.; Tobiczyk, E.; Mostovoy, Y.; Barczyk, A.

dc.contributor.author	Poberezhets, V.
dc.contributor.author	Skoczyński, S.
dc.contributor.author	Demchuk, A.
dc.contributor.author	Oraczewska, A.
dc.contributor.author	Tobiczyk, E.
dc.contributor.author	Mostovoy, Y.
dc.contributor.author	Barczyk, A.
dc.date.accessioned	2025-03-23T14:32:49Z
dc.date.available	2025-03-23T14:32:49Z
dc.date.issued	2020
dc.identifier.citation	Impact of comorbidities on the deterioration of skeletal muscle dysfunction among COPD patients / V. Poberezhets, S. Skoczynski, A. Demchuk, [et al.] // EUROPEAN RESPIRATORY JOURNAL. – 2020. – № 56(suppl 64). – P. 700.	uk_UA
dc.identifier.issn	1399-3003
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/8773
dc.description.abstract	The prevalence of comorbidity among COPD patient was high and was associated with reduced muscle strength, muscle quantity and low physical performance. Therefore, the presence of comorbidities leads to the deterioration of SMD among COPD patients.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	European Respiratory Journal	uk_UA
dc.subject	comorbidities	uk_UA
dc.subject	skeletal muscle dysfunction	uk_UA
dc.subject	COPD	uk_UA
dc.title	Impact of comorbidities on the deterioration of skeletal muscle dysfunction among COPD patients	uk_UA
dc.type	Thesis	uk_UA